The company reported third-quarter gains of 24 percent for hip implants, to $6.8 million; 4 percent for knee implants, to $17.3 million; and 7 percent for biologic and spine, to $6.5 million.
Total revenue for the first nine months of 2009 rose 6 percent, to $129 million, over the same period last year.
Read Exactech’s release on third-quarter sales.